Recent Publications

2019
Peer Review Publications
Toivonen J, Montoya Perez I, Movahedi P, Merisaari H, Pesola M, Taimen P, Boström PJ, Pohjankukka J, Kiviniemi A, Pahikkala T, Aronen HJ, Jambor I. Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization. PLoS One. 2019 Jul 8;14(7):e0217702.
Jambor I, Verho J, Ettala O, Knaapila J, Taimen P, Syvänen KT, Kiviniemi A, Kähkönen E, Perez IM, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Aronen HJ, Boström PJ. Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial. PLoS Med. 2019 Jun 3;16(6):e1002813.
Saarinen I, Jambor I, Kim M, Kuisma A, Kemppainen J, Merisaari H, Eskola O, Koskenniemi AR, Perez IM, Boström P, Taimen P, Minn H. Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer. EJNMMI Res. 2019 May 31;9(1):50.
Merisaari H, Jambor I, Ettala O, Boström PJ, Montoya Perez I, Verho J, Kiviniemi A, Syvänen K, Kähkönen E, Eklund L, Pahikkala T, Vainio P, Saunavaara J, Aronen HJ, Taimen P. IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy. J Magn Reson Imaging. 2019 Mar 22. doi: 10.1002/jmri.26727
Merisaari H, Tuulari JJ, Karlsson L, Scheinin NM, Parkkola R, Saunavaara J, Lähdesmäki T, Lehtola SJ, Keskinen M, Lewis JD, Evans AC, Karlsson H. Test-retest reliability of Diffusion Tensor Imaging metrics in neonates. Neuroimage. 2019 Aug 15;197:598-607.
Pulli EP, Kumpulainen V, Kasurinen JH, Korja R, Merisaari H, Karlsson L, Parkkola R, Saunavaara J, Lähdesmäki T, Scheinin NM, Karlsson H, Tuulari JJ. Prenatal exposures and infant brain: Review of magnetic resonance imaging studies and a population description analysis. Hum Brain Mapp. 2019 Apr 15;40(6):1987-2000.
Lehtola SJ, Tuulari JJ, Karlsson L, Parkkola R, Merisaari H, Saunavaara J, Lähdesmäki T, Scheinin NM, Karlsson H. Associations of age and sex with brain volumes and asymmetry in 2-5-week-old infants. Brain Struct Funct. 2019 Jan;224(1):501-513.
Laurikainen H, Tuominen L, Tikka M, Merisaari H, Armio RL, Sormunen E, Borgan F, Veronese M, Howes O, Haaparanta-Solin M, Solin O, Hietala J; METSY group. Sex difference in brain CB1 receptor availability in man. Neuroimage. 2019 Jan 1;184:834-842.
Tuulari JJ, Scheinin NM, Lehtola S, Merisaari H, Saunavaara J, Parkkola R, Sehlstedt I, Karlsson L, Karlsson H, Björnsdotter M. Neural correlates of gentle skin stroking in early infancy. Dev Cogn Neurosci. 2019 Feb;35:36-41.
Arvola S, Jambor I, Kuisma A, Kemppainen J, Kajander S, Seppänen M, Noponen T. Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer. EJNMMI Res. 2019 Jan 24;9(1):6.
Abstracts
Jambor I, Verho J, Otto Ettala, Knaapila J, Taimen P, Syvänen K, Kiviniemi A, Kähkönen E, Perez IM, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki K, Mirtti T, Lamminen T, Saunavaara J, Aronen HJ, Boström PJ. Prospective multi-institutional validation of IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (MULTI- IMPROD trial). ISMRM, Montreal, Canada, 2019
Perez IM, Pahikkala T, Airola A, Merisaari H, Taimen P, Alinezhad S, Verho J, Ettala O, Saunavaara J, Pettersson K, Boström PJ, Aronen HJ, Jambor I. Prostate cancer detection in men with a clinical suspicion prostate cancer using IMPROD biparametric MRI and expression of 11 genes (IMPROD trial, #opensourcetrial): evaluation using machine learning methods. ISMRM, Montreal, Canada, 2019
Jambor I, Perez IM, Verho J, Ettala O, Knaapila J, Taimen P, Syvänen KT, Kiviniemi A, Kähkönen E, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Pahikkala T, Aronen HJ, Boström PJ. Development and external validation of IMPROD biparametric MRI- based nomogram for the prediction of prostate biopsy outcome in men with a clinical suspicion of prostate cancer (IMPROD and MULTI- IMPROD trials, #opensourcetrial). ISMRM, Montreal, Canada, 2019
Merisaari H, Shiradkar R, Toivonen J, Hiremath A, Khorrami M, Perez IM, Pahikkala T, Taimen P, Verho J, Boström PJ, Aronen HJ, Madabhushi A, Jambor I. Repeatability of radiomic features for prostate cancer diffusion weighted imaging obtained using b-values up to 2000 s/mm2. ISMRM, Montreal, Canada, 2019
2018
Peer Review Publications
Salminen A, Jambor I, Merisaari H, Ettala O, Virtanen J, Koskinen I, Veskimae E, Sairanen J, Taimen P, Kemppainen J, Minn H, Boström PJ. 11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial). Cancer Imaging. 2018 Aug 2;18(1):25.
Perez IM, Airola A, Boström PJ, Jambor I, Pahikkala T. Tournament leave-pair-out cross-validation for receiver operating characteristic analysis. Stat Methods Med Res. 2018 Aug 20:962280218795190. doi: 10.1177/0962280218795190
Shiradkar R, Ghose S, Jambor I, Taimen P, Ettala O, Purysko AS, Madabhushi A. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings. J Magn Reson Imaging. 2018 May 7. doi: 10.1002/jmri.26178.
Knaapila J, Kallio H, Hakanen AJ, Syvänen K, Ettala O, Kähkönen E, Lamminen T, Seppänen M, Jambor I, Rannikko A, Riikonen J, Munukka E, Eerola E, Gunell M, Boström PJ. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study. BJU Int. 2018 Mar 13. doi: 10.1111/bju.14198.
Algohary A, Viswanath S, Shiradkar R, Ghose S, Pahwa S, Moses D, Jambor I, Shnier R, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Purysko AS, Verma S, Ponsky L, Stricker P, Madabhushi A. Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings. J Magn Reson Imaging. 2018 Feb 22. doi: 10.1002/jmri.25983.
Jambor I, Kuisma A, Kähkönen E, Kemppainen J, Merisaari H, Eskola O, Teuho J, Perez IM, Pesola M, Aronen H, Boström P, Taimen P, Minn H. Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial). Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):355-364.
Knaapila J, Gunell M, Syvänen K, Ettala O, Kähkönen E, Lamminen T, Seppänen M, Jambor I, Rannikko A, Riikonen J, Munukka E, Eerola E, Hakanen AJ, Boström PJ. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort. Eur Urol Focus. pii: S2405-4569(17)30270-5
Abstracts
Merisaari H, Kiviniemi A, Pesola M, Liimataien T, Sucksdorff M, Rissinen E, Airas L, Aronen HJ, Jambor I. Whole brain adiabatic T1rho and Relaxation Along a Fictitious Field imaging in healthy volunteers and patients with multiple sclerosis: initial findings. RSNA, Chicago, USA, 2018
Jambor I, Merisaari H, Kiviniemi A, Ettala O, Syvänen K, Kähkönen E, Saunavaara J, Verho J, Boström PJ, Aronen HJ, Taimen P. Accuracy of IMPROD pre-biopsy biparametric MRI for the detection of prostate cancer in men before their first biopsy: correlation with whole mount prostatectomy sections and implication for focal therapy. RSNA, Chicago, USA, 2018
Movahedi P, Merisaari H, Perez IM, Toivonen J, Taimen P, Boström P, Verho J, Aronen H, Pahikkala T, Jambor I. Bi-exponential modeling of prostate diffusion weighted MR imaging acquired using high b values: clinical evaluations of advanced post-processing methods. ISMRM, Paris, France, 2018
Perez IM, Toivonen J, Movahedi P, Merisaari H, Verho J, Taimen P, Boström P, Pahikkala T, Aronen H, Jambor I. Computer aided quantification of prostate cancer diffusion-weighted imaging: repeatability analysis of radiomics as biomarkers for Gleason score prediction. ISMRM, Paris, France, 2018
Toivonen J, Perez IM, Movahedi P, Merisaari H, Verho J, Taimen P, Boström P, Pahikkala T, Aronen H, Jambor I. Machine learning for prostate cancer Gleason score prediction using radiomics of T2-weighted imaging, diffusion weighted imaging and T2-mapping. ISMRM, Paris, France, 2018
Movahedi P, Merisaari H, Laakso H, Perez IM, Liljenbäck H, Aronen H, Minn H, Roivainen A, Liimatainen T, Jambor I. Spatially constrained mathematical models for diffusion weighted imaging of prostate cancer xenografts in mice: evaluation of therapy response. ISMRM, Paris, France, 2018
2017
Peer Review Publications
Jambor I, Boström PJ, Taimen P, Syvänen K, Kähkönen E, Kallajoki M, Perez IM, Kauko T, Matomaki J, Ettala O, Merisaari H, Kiviniemi A, Dean PB, Aronen HJ. Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD trial) J Magn Reson Imaging. 2017 Oct;46(4):1089-1095
Einarsdottir E, Peyrard-Janvid M, Darki F, Tuulari JJ, Merisaari H, Karlsson L, Scheinin NM, Saunavaara J, Parkkola R, Kantojärvi K, Ämmälä AJ, Yiu-Lin Yu N, Matsson H, Nopola-Hemmi J, Karlsson H, Paunio T, Klingberg T, Leinonen E, Kere J. Identification of NCAN as a candidate gene for developmental dyslexia. Sci Rep. 2017 Aug 24;7(1):9294.
Ginsburg S, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A. Radiomic Features for Prostate Cancer Detection on MRI Differ Between the Transition and Peripheral Zones: Preliminary Findings from a Multi-Institutional Study J Magn Reson Imaging. 2017 Jul;46(1):184-193
Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala T, Kiviniemi A, Aronen HJ, Jambor I. Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction. Magn Reson Med. 2017 Mar;77(3):1249-1264.
Conference Publications
Perez IM, Toivonen J, Movahedi P, Merisaari H, Pesola M, Taimen P, Boström PJ, Kiviniemi A, Aronen HJ, Pahikkala T, Jambor I. Diffusion weighted imaging of prostate cancer: Prediction of cancer using texture features from parametric maps of the monoexponential and kurtosis functions, in 2016 6th International Conference on Image Processing Theory, Tools and Applications, IPTA 2016, 2017 Jan.
Abstracts
Jambor I, Movahedi P, Merisaari H, Kemppainen J, Taimen P, Minn H. Towards improved Gleason score prediction using 18F-FACBC (Fluciclovine) PET and MRI: evaluation of advanced post-processing methods using machine learning. RSNA, Chicago, USA, 2017
Jambor I, Taimen P, Kiviniemi A, Perez IM, Ettala O, Kähkönen E, Syvänen K, Kallajoki M, Boström PJ, Aronen HJ. Validation of a prospective quantitative evaluation of Gleason score prediction using prostate diffusion weighted imaging: a single institution experience in 293 men with a clinical suspicion of prostate cancer. RSNA, Chicago, USA, 2017
Jambor I, Taimen P, Kiviniemi A, Ettala O, Kähkönen E, Syvänen K, Seppanen M, Oksanen O, Rannikko A, Matikainen M, Riikonen J, Vimpeli S-M, Kallajoki M, Perez IM I, Dean P, Boström PJ, Aronen HJ. Biparametric MRI and targeted biopsy in men with elevated PSA before their first biopsy: prospective qualitative and quantitative reporting in a multi-institutional registered clinical trial (Multi-IMPROD). RSNA, Chicago, USA, 2017
Jambor I, Kiviniemi A, Taimen P, Ettala O, Kähkönen E, SSyvänen K, Seppanen M, Oksanen O, Rannikko A, Matikainen M, Riikonen J, Vimpeli SM, Kallajoki M, Dean P, Hannu Aronen HJ, Boström PJ. Development and validation of biparametric MRI followed by targeted biopsy in men with a clinical suspicion of prostate cancer: IMPROD and Multi-IMPROD clinical trials, RSNA, Chicago, USA, 2017
Jambor I, Kemppainen J, Merisaari H, Eskola O, Kähkönen E, Boström PJ, Taimen P, Minn H. 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial): prostate cancer detection and characterization. ISMRM-SNMMI workshop, Chicago, USA, 2017
Jambor I, Salminen A, Ettala O, Merisaari M, Eskola JV, Koskinen I, Veskimae E, Sairanen J, Minn H, Kemppainen J, Boström PJ. 11C-acetate PET/MRI in bladder cancer staging: ACEBIB trial. ISMRM-SNMMI workshop, Chicago, USA, 2017
2016
Peer Review Publications
Ginsburg S, Taimen P, Merisaari M, Vainio V, Boström PJ, Aronen HJ, Jambor I, Madabhushi A. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method. J Magn Reson Imaging. 2016 Dec;44(6):1405-1414.
Alinezhad S, Väänänen RM, Tallgrén T, Perez IM, Jambor I, Aronen H, Kähkönen E, Ettala O, Syvänen K, Nees M, Kallajoki M, Taimen P, Boström PJ, Pettersson K. Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue. Urol Oncol. 2016 Jun;34(6):255.e15-22.
Jambor I, Pesola M, Merisaari H, Taimen P, Boström P, Liimatainen T, Aronen HJ. Relaxation along fictitious field, diffusion weighted imaging, and T2 mapping of prostate cancer: prediction of cancer aggressiveness. Magn Reson Med. 2016 May;75(5):2130-40.
Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander K, Kemppainen J, Kauppila E, Auren J, Merisaari H, Saunavaara J, Noponen N, Minn H, Aronen HJ, Seppänen M. Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol. 2016 Jan;55(1):59-67.
Jambor I, Pesola M, Liimatainen T, Merisaari H, Boström P, Minn H, Taimen P, Aronen HJ. Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction. Magn Reson Med. 2016 Jan;75(1):337-44.
Abstracts
Jambor I, Boström PJ, Taimen P, Kähkönen E, Kallajoki M, Kauko T, Perez IM, Ettala O, Merisaari H, Syvänen K, Aronen HJ. Rapid pre-biopsy MRI in patients with a clinical suspicion of prostate cancer: results of a controlled prospective registered IMPROD-trial. ISMRM, Singapore, 2016
Kiviniemi A, Merisaari H, Pesola M, Liimatainen T, Aronen HJ, Jambor I. Whole brain adiabatic T1rho and Relaxation Along a Fictitious Field imaging in healthy volunteers: feasibility and initial findings. ISMRM, Singapore, 2016
Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, Boström P, Pahikkala T, Aronen HJ, Jambor I. Diffusion weighted imaging of prostate cancer: mathematical modeling of signal obtained using low b values. ISMRM, Singapore, Singapore, 2016
Movahedi P, Hakkarainen H, Merisaari H, Liljenbäck H, Virtanen H, Aronen HJ, Minn H, Poutanen M, Roivainen A, Liimatainen T, Jambor I. Diffusion weighted imaging of prostate cancer xenografts: comparison of bayesian modeling and independent least squares fitting. ISMRM, Singapore, 2016
2015
Peer Review Publications
Salminen AP, Jambor I, Syvänen KT, Boström PJ. Lymph node imaging in bladder cancer. Minerva Urol Nefrol. 2015 Dec 18.
Merisaari H, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala T, Aronen HJ, Jambor I. Diffusion weighted imaging of prostate cancer: Effect of b-value distribution on repeatability and cancer characterization. Magn Reson Imaging. 2015 Dec;33(10):1212-8.
Toivonen J, Merisaari H, Pesola M, Taimen P, Boström P, Pahikkala T, Aronen HJ, Jambor I. Mathematical models for diffusion weighted imaging of prostate cancer using b-values up to 2000 s/mm2: correlation with Gleason score and repeatability of region of interest analysis. Magn Reson Med. 2015 Oct;74(4):1116-24.
Jambor I, Kähkönen E, Taimen P, Merisaari H, Saunavaara J, Alanen K, Obsitnik B, Minn H, Lehotska V, Aronen HJ. Pre-biopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination and no previous biopsy. J Magn Reson Imaging 2015 May;41(5):1394-404
Jambor I, Merisaari H, Taimen P, Saunavaara J, Alanen K, Boström, Minn H, Pesola M, Aronen HJ. Evaluation of different mathematical models for diffusion weighted MR imaging of normal prostate and prostate cancer using high b-values: repeatability study. Magn Reson Med. 2015 May;73(5):1988-98.
Merisaari H, Jambor I. Optimization of b-value distribution for four mathematical models of prostate cancer diffusion-weighted imaging using b values up to 2000 s/mm2: simulation and repeatability study. Magn Reson Med. 2015 May;73(5):1954-69.
Abstracts
Jambor I, Pesola M, Merisaari H, Taimen P, Boström PJ, Liimatainen T, Aronen HJ. Relaxation along fictitious field, diffusion weighted imaging, and T2 mapping of prostate cancer: correlation of quantitative values with Gleason score. ISMRM, Toronto, Canada, 2015
Merisaari H, Hakkarainen H, Liljenbäck H, Ahtinen H, Minn H, Poutanen M Roivainen A, Tiimatainen T, Jambor I. Evaluation of different mathematical models for diffusion weighted imaging of prostate cancer xenografts in mice. ISMRM, Toronto, Canada, 2015
Merisaari H, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala P, Aronen HJ, Jambor I. Evaluation of b-value distributions for monoexponential model of prostate cancer diffusion-weighted imaging using b values up to 2000 s/mm2: a repeatability study on region of interest level. ISMRM, Toronto, Canada, 2015
2014
Peer Review Publications
Jambor I, Merisaari H, Aronen HJ, Järvinen J, Saunavaara J, Kauko T, Borra R, Pesola M. Optimization of b-value distribution for bioexponential diffusion-weighted MR imaging of normal prostate. J Magn Reson Imaging. 2014 May;39(5):1213-22.
Abstracts
Jambor I, Boström PJ, Taimen P, Kähkönen E, Kallajoki M, Merisaari H, Saunavaara J, Syvänen K, Aronen HJ. Pre-biopsy anatomical T2-weighted and diffusion weighted MR imaging in patients with a clinical suspicion of prostate cancer: IMPROD clinical trial. RSNA, Chicago, USA, 2014
Merisaari H, Jambor I. Optimization of b-value distribution for four mathematical models of prostate cancer diffusion-weighted imaging using b-values up to 2000 s/mm2: simulation and repeatability study. RSNA, Chicago, USA, 2014
Jambor I, Liimatainen T, Merisaari H, Boström P, Minn H, Aronen HJ, Pesola M. Rotating frame relaxation imaging of prostate cancer: a feasibility study. ISMRM, Milan, Italy, 2014
Jambor I, Kähkönen E, Taimen P, Saunavaara J, Merisaari H, Alanen K, Obsitnik B, Minn H, Lehotska V, Aronen HJ. Multiparametric 3T prostate MRI in patients with elevated PSA and no previous biopsy. ISMRM, Milan, Italy, 2014
Hakkarainen H, Jambor I, Poutanen M, Liljenbäck H, Ahtinen H, Roivainen A, Minn H, Martikainen M, Liimatainen Timo. Rotating frame relaxation measurements in prostate cancer model. ISMRM, Milan, Italy, 2014
2013
Peer Review Publications
Boccardi M, Bocchetta M, Aronen HJ, Repo-Tiihonen E, Vaurio O, Thompson PM, Tiihonen J, Frisoni GB. Atypical nucleus accumbens morphology in psychopathy. another limbic piece in the puzzle. Int J Law Psychitatry 2013;36:157-167.
Toivonen P, Könönen M, Niskanen E, Vaurio O, Repo-Tiihonen E, Aronen HJ, Vanninen R, Tiihonen J, Laakso MP. Cavum septum pellucidum and psychopathy. Br J Psychiatry 2013;203:152-153.
Kähkönen E, Jambor I, Kemppainen J, Lehtiö K, Silén J, Kuisma J, Luoto P, Tolvanen T, Alanen K, Grönroos T, Kallajoki M, Roivainen A, Schäfer N, Schibli R, Dragic M, Johayem M, Valencia R, Borkowski S, Minn H. In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548. Clin Cancer Res. 2013 Oct 1;19(19):5434-43.
Abstracts
Jambor I, Kuisma A, Huovinen R, Sandell M, Auren J, Kajander S, Kemppainen J, Saunavaara J, Noponen T, Minn H, Aronen HJ, Seppänen M. Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NaF PET/CT and whole body 1.5T MRI for detection of bone metastases in high risk breast and prostate cancer patients. RSNA, Chicago, USA, 2013
Jambor I, Liimatainen T, Paijula J, Boström P, Minn H, Aronen HJ, Pesola M. Rotating frame RAFF and T1rho imaging of prostate cancer: a feasibility study. ESMRMB, Toulouse, France, 2013
Jambor I, Kauko T, Merisaari H, Järvinen J, Saunavaara J, Pesola M, Aronen HJ. Reliability and repeatability of apparent diffusion coefficient value of normal prostate. ESMRMB, Toulouse, France, 2013
Merisaari H, Jambor I, Huang X, Han C, Pesola M, Aronen HJ. Statistical evaluation of different mathematical models for diffusion weighted imaging of normal prostate: repeatability study. ESMRMB, Toulouse, France, 2013
Jambor I, Järvinen J, Merisaari H, Aronen HJ, Saunavaara J, Kauko T, Borra R, Pesola M. Optimization of b-value distribution for biexponential diffusion-weighted MR imaging of normal prostate. ISMRM, Salt Lake City, USA, 2013
2012
Peer Review Publications
Jambor I, Borra R, Kemppainen J, Lepomäki V, Parkkola R, Dean K, Alanen K, Arponen E, Nurmi M, Aronen HJ, Minn H. Improved detection of localized prostate cancer using dynamic contrast enhanced MRI and 11C-acetate PET/CT - correlation with biopsy findings. Eur J Radiol 2012;81:2966-2972.
Abstracts
Jambor I, Borra R, Kemppainen J, Lepomäki V, Dean K, Alanen K, Nurmi M, Aronen HJ, Minn H. Detection of localized prostate cancer using contrast enhanced MRI and 11C-acetate PET/CT. ECR, Vienna, Austria, 2012